Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population
Advances in Lung Cancer · 2014
DOI: 10.4236/alc.2014.31001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Lung Cancer, 2014. Verfasst von Shuichi Tsukamoto und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tsukamoto, S., Yamazaki, K., Mori, R., Katsura, M., Kouso, H., Kawano, D., Ushijima, C., & Takeo, S. (2014). Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population. Advances in Lung Cancer. https://doi.org/10.4236/alc.2014.31001
Vancouver
Tsukamoto S, Yamazaki K, Mori R, Katsura M, Kouso H, Kawano D, et al. Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population. Advances in Lung Cancer. 2014. doi:10.4236/alc.2014.31001
BibTeX
@article{Tsukamoto2014,
author = {Tsukamoto, Shuichi and Yamazaki, Koji and Mori, Ryo and Katsura, Masakazu and Kouso, Hidenori and Kawano, Daigo and Ushijima, Chie and Takeo, Sadanori},
title = {Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population},
journal = {Advances in Lung Cancer},
year = {2014},
doi = {10.4236/alc.2014.31001}
}
EUVIMED